Today marks the one-year anniversary of the passing of Dr. Paolo Chiesi, former Honorary President of Chiesi Group.

Dr. Paolo Chiesi was a visionary leader and a cornerstone of Chiesi Group for almost sixty years. His contributions to scientific progress and innovation have left a lasting impact on the company and the global community.
 

Throughout his tenure, he provided invaluable guidance to the Research & Development department. His legacy includes over 50 patents and numerous scientific publications, reflecting his relentless pursuit of excellence.
 

Beyond his groundbreaking work, Dr. Paolo Chiesi was a source of inspiration to all who had the privilege of working with him. His profound scientific expertise, combined with his remarkable humanity, made him an extraordinary mentor and leader.
 

Dr. Paolo Chiesi's passion and dedication continue to inspire us every day. We remain forever grateful for his guidance and the significant impact he has had on our lives and our work.

 

About his career
 

Dr. Paolo Chiesi took his undergraduate degree in Chemistry at the University of Parma in 1964, and he graduated in Pharmacy at the same University in 1965. Shortly after, he began his professional career at Chiesi Group. 

From 1985 to July 2023, Dr. Paolo served as Vice President of the Group. Leading the Research & Development department, he played a pivotal role in advancing therapies for respiratory, neonatal, and rare diseases.
 

In 2015, Dr. Paolo together with his brother Alberto, has been awarded by the Ernst & Young as the EY World Entrepreneur of the Year in the field of Healthcare and Life Science.
 

Dr. Paolo Chiesi was particularly active also in the field of international health cooperation. In 2005, he founded and chaired the Chiesi Foundation until 2021, championing initiatives to improve access to quality care for patients with chronic respiratory diseases in Latin America and for newborns and their mothers in Sub-Saharan Africa.

In 2010, he received an honorary degree in Medicine from the University of Modena and Reggio Emilia, while in 2019 he has been appointed Honorary doctor at Karolinska Institutet for his long-standing commitment to vital treatment of the lungs of premature babies.